Spending some time this afternoon at the #BiotechShowcase (or so you might have heard). Looking forward to the Lunch Plenary: “Mega A-Rounds, Mega IPOs and consolidation”
-
-
@pharmaprodigy notes typically there are half as many IPOs in an election year.#BiotechShowcasePrikaži ovu nit -
Jeanne Cunicelli of UPMC Enterprises says they’d like to be part of big VC rounds, but only for the right companies. Notes that smaller rounds are just right-sized for those companies.
#BiotechShowcasePrikaži ovu nit -
SVB Leerink’s Cavazos says crossover VC rounds that bring in future IPO investors to companies are not going away. They used to be a nice to how & now a must have. Companies that do crossover rounds do better in their IPOs.
#BiotechShowcasePrikaži ovu nit
Kraj razgovora
Novi razgovor -
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.